ROTHSCHILD INVESTMENT LLC /IL - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROTHSCHILD INVESTMENT LLC /IL ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$447
-1.8%
28,926
-0.2%
0.04%0.0%
Q2 2023$455
-4.4%
28,992
+0.3%
0.04%
-9.5%
Q1 2023$476
+0.6%
28,899
-4.7%
0.04%
-2.3%
Q4 2022$473
-99.9%
30,322
-1.0%
0.04%
+10.3%
Q3 2022$397,000
-8.1%
30,619
-0.5%
0.04%
-2.5%
Q2 2022$432,000
-2.5%
30,774
-0.5%
0.04%
+14.3%
Q1 2022$443,000
+5.2%
30,9190.0%0.04%
+6.1%
Q4 2021$421,000
-20.1%
30,919
-3.9%
0.03%
-25.0%
Q3 2021$527,000
-4.9%
32,177
-2.2%
0.04%0.0%
Q2 2021$554,000
-11.8%
32,906
-4.4%
0.04%
-18.5%
Q1 2021$628,000
+6.1%
34,410
+5.7%
0.05%
-5.3%
Q4 2020$592,000
+0.9%
32,548
-1.1%
0.06%
-10.9%
Q3 2020$587,000
+1.9%
32,904
+2.4%
0.06%
-7.2%
Q2 2020$576,000
+15.4%
32,125
-2.3%
0.07%
+6.2%
Q1 2020$499,000
-22.4%
32,870
+0.8%
0.06%
+1.6%
Q4 2019$643,000
+14.6%
32,6140.0%0.06%
-1.5%
Q3 2019$561,000
-2.8%
32,6140.0%0.06%
-4.4%
Q2 2019$577,000
-15.8%
32,614
-3.0%
0.07%
-15.0%
Q1 2019$685,00033,6200.08%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders